Clinical Trials
10 trialsNCT01107522 2025-09-09
Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas
Tactical Therapeutics, Inc.
Phase 1 Unknown
NCT06368960 2024-04-16
BM201-1001
InnoBM Pharmaceuticals Co., Ltd.
Phase 1 Unknown
NCT00643318 2021-03-05
CyberKnife Radiosurgical Treatment of Inoperable Early Stage Non-Small Cell Lung Cancer
Accuray Incorporated
Phase 2 Unknown
NCT03780569 2018-12-20
TTFields Together With Temozolomide and Radiotherapy in Patients With Newly Diagnosed GBM
NovoCure Ltd.
Phase NA Unknown
NCT02985255 2016-12-07
Role of Neo-adjuvant Chemotherapy in Tongue Preservation in Locally Advanced Squamous Cell Carcinoma of Oral Tongue
HealthCare Global Enterprise Ltd.
Phase 2 Unknown
NCT02202928 2015-12-28
Adoptive Cell Therapy Plus Chemotherapy and Radiation After Surgery in Treating Patients With Colorectal Cancer
Shenzhen Hornetcorn Bio-technology Company, LTD
Phase 2 Unknown
NCT01368419 2013-04-24
Continuous Endostar Infusion Combined With Radiotherapy in Esophageal Cancer Patients
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 2 Unknown
NCT00894153 2012-04-09
p53 Gene Therapy for Head and Neck Malignant Tumors in Advanced Stage
Shenzhen SiBiono GeneTech Co.,Ltd
Phase 4 Unknown
NCT00768911 2010-10-27
CT-322 in Combination With Radiation Therapy and Temozolomide to Treat Newly Diagnosed Glioblastoma Multiforme
Adnexus, A Bristol-Myers Squibb R&D Company
Phase 1 Unknown
NCT00394628 2007-05-30
AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme
Novacea
Phase 1/2 Unknown